|
|
|
Volumn 9, Issue 4, 1999, Pages 240-245
|
|
Can OI prophylaxis be stopped in patients responding to HAART?
|
|
Author keywords
Antiretroviral therapy; Cryptococcus; Cytomegalovirus (CMV); Infection, opportunistic; Mycobaterium avium complex (MAC); Pneumocystis carinii pneumonia (PCP); Toxoplasmosis
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
AZITHROMYCIN;
CLARITHROMYCIN;
COTRIMOXAZOLE;
DAPSONE;
RIFABUTIN;
ANTIINFECTIVE AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
HELPER CELL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MYCOBACTERIOSIS;
OPPORTUNISTIC INFECTION;
PNEUMOCYSTIS PNEUMONIA;
PROPHYLAXIS;
SHORT SURVEY;
T LYMPHOCYTE SUBPOPULATION;
TOXOPLASMOSIS;
CD4 LYMPHOCYTE COUNT;
DECISION MAKING;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
IMMUNOLOGY;
PRACTICE GUIDELINE;
REVIEW;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-INFECTIVE AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
DECISION MAKING;
HUMANS;
OPPORTUNISTIC INFECTIONS;
PRACTICE GUIDELINES;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
|
|
EID: 0032797064
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (31)
|
